In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1850 News Items found
Pictured: Memorial Sloan Kettering logo
In the News
Memorial Sloan Kettering Made Major Contributions to Cancer Advances in 2011

Two of the year's top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators.
Pictured: Eric Pamer
In the Lab
Researchers Shed Light on Possible Cause of Infections in Cancer Patients

Infections are a common cause of complications in cancer patients. Now a Memorial Sloan Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.
Pictured: Michael Morris
In the Clinic
Bone Scan Index May Help Determine Response to Prostate Cancer Treatment

Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.
Five Memorial Sloan Kettering researchers have been named to Stand Up To Cancer's new Melanoma "Dream Team."
Honors
Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Melanoma “Dream Team”

Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.
Pictured: Structural formula of IBNtxA
In the Lab
Findings Could Lead to the Development of a New Painkiller

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.
Pictured: Breast tumor treated with paclitaxel
In the Lab
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.
Pictured: Hans-Guido Wendel
Profile
Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.
Pictured: Gabriela Chiosis
Out of the Lab and into the World: Hsp90 Inhibitor, a New Cancer Drug

A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer.
An illustration
Feature
Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.
Pictured: Milind Rajadhyaksha, Snehal Patel & Ricardo Toledo-Crow
Out of the Lab and into the World: The Endoscopic Laser Scalpel

A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe.